C3 and age-related macular degeneration: A recent study by Heesterbeek and colleagues revealed a small but statistically significant increase in serum C3d/C3 ratios, a marker of complement activation, in patients with intermediate AMD or central GA versus patients without AMD [23], supporting that chronic, low systemic complement dysregulation may contribute to AMD.